Higher Levels of Endogenous Estradiol are Associated with Frailty in Postmenopausal Women from the Toledo Study for Healthy Aging | Zendy

Laure CarcaillonBentata | Zendy; Francisco J. GarcíaGarcía | Zendy; J. A. F. Tresguerres | Zendy; Guillermo Gutiérrez Avila | Zendy; Roman Kireev | Zendy; Leocadio Rodrı́guez-Mañas | Zendy

Open Access

Higher Levels of Endogenous Estradiol are Associated with Frailty in Postmenopausal Women from the Toledo Study for Healthy Aging

Author(s) -

Laure CarcaillonBentata,

Francisco J. GarcíaGarcía,

J. A. F. Tresguerres,

Guillermo Gutiérrez Avila,

Roman Kireev,

Leocadio Rodrı́guez-Mañas

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-1271

Subject(s) - medicine , odds ratio , confidence interval , body mass index , logistic regression , cohort study , frailty syndrome , cohort , population , endocrinology , gerontology , frailty index , environmental health

Adverse effects of higher endogenous estradiol (E2) levels on various clinical outcomes and on determinants of the frailty syndrome have recently been reported. However, there are no data about the potential relationship between E2 and frailty. We aimed to study the association between E2 levels and frailty among older postmenopausal women not taking hormonal therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research